Bab's Hobbs Pharma Guide

Tag: FDA

REMS for Isotretinoin: iPLEDGE Requirements and Safety in 2025
Justine Traver

REMS for Isotretinoin: iPLEDGE Requirements and Safety in 2025

iPLEDGE is the FDA's strict program to prevent birth defects from isotretinoin. Learn the 2025 requirements, recent changes, and how to navigate the system safely.

31 Dec 2025

Browse by category

  • Health & Wellness (222)

Latest news

  • How to Verify Pharmacy Licenses Through State Pharmacy Boards to Avoid Counterfeit Drugs
  • Montelukast for Allergic Airways: What You Need to Know About Leukotriene Inhibitors
  • Choosing a Sulfonylurea: Side Effect Differences and Hypoglycemia Risk
  • Dry Mouth and Bad Breath: Causes, Connections, and Real-Life Freshening Tips
  • Alcoholic Liver Disease: Understanding the Stages from Fatty Liver to Cirrhosis

Posts Tags

  • drug interactions
  • online pharmacy
  • side effects
  • medication safety
  • bioequivalence
  • online pharmacy safety
  • medication reconciliation
  • patient safety
  • medication side effects
  • Hatch-Waxman Act
  • generic drugs
  • medication errors
  • generic medications
  • expired medications
  • medication adherence
  • generic medication
  • patent expiration
  • authorized generics
  • narrow therapeutic index
  • generic drug safety
Bab's Hobbs Pharma Guide
Menu
  • About
  • Terms of Service
  • Privacy Policy
  • GDPR Compliance
  • Contact

© 2026. All rights reserved.